Rahul Banerjee, MD

Title(s)Volunteer Clinical Instructor, Medicine
SchoolSchool of Medicine
AddressFlexible, #001
Varies
ORCID ORCID Icon0000-0003-3781-5441 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Alpert Medical School of Brown University, Providence, RIMD05/2014(Medical School)
    Hospital of the University of Pennsylvania, Philadelphia, PAResidency06/2017Internal Medicine
    Philadelphia VA Medical Center, Philadelphia, PAChief Residency06/2018Quality Improvement
    UCSF, San Francisco, CAFellowship06/2021Hematology & Oncology
    UCSF, San Francisco, CAAdvanced Fellowship06/2022BMT/CAR-T Therapy
    Collapse Awards and Honors
    American Society of Clinical Oncology2019ASCO/AACR Methods in Clinical Cancer Research Workshop (Vail, CO)
    American Society for Transplantation and Cellular Therapy2019ASTCT Clinical Research Training Course (Park City, UT)
    University of California San Francisco2019  - 2020Chief Fellow, Division of Hematology/Oncology
    Warren Alpert Medical School (Brown University)2014Alpha Omega Alpha Honor Medical Society
    Warren Alpert Medical School (Brown University)2014Gold Humanism Honor Society
    American College of PhysiciansElectee, Fellow of the American College of Physicians (FACP)

    Collapse Research 
    Collapse Research Activities and Funding
    Efficacy of digital life coaching to lower benzodiazepine usage and improve quality of life in multiple myeloma patients undergoing transplantation
    ASCO Conquer Cancer Foundation Young Investigator AwardJul 1, 2020 - Dec 31, 2021
    Role: Principal Investigator
    Description: The goal of this study is to assess whether digital access to a trained life coach via phone calls and text messages can improve patient-reported outcomes during stem cell transplantation.

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma. Blood Cancer J. 2024 Oct 16; 14(1):180. Fortuna GG, Banerjee R, Savid-Frontera C, Song J, Morán-Segura CM, Nguyen JV, Lekakis L, Fernandez-Pol S, Samraj AN, Naresh KN, Vazquez-Martinez M, Baz RC, Spiegel JY, Mikkilineni L, Gubatan JM, Sidana S, de Menezes Silva Corraes A, Kalariya NM, Patel KK, Shim KG, Fonseca R, Ferreri C, Voorhees PM, Richard S, Valdes CR, Wolf JL, Cowan AJ, Sborov DW, Locke FL, Lin Y, Wang Y, Hansen DK. PMID: 39414769; PMCID: PMC11484697.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Smartwatch Biometrics in the Electronic Medical Record: Time for a New Vital Sign? JCO Clin Cancer Inform. 2024 Sep; 8:e2400161. Sankaran S, Banerjee R. PMID: 39348623.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis. Blood. 2024 Sep 25. Banerjee R, Sexton R, Cowan AJ, Rosenberg AS, Ailawadhi S, Rajkumar SV, Kumar SK, Dispenzieri A, Lonial S, Durie BGM, Richardson PG, Usmani SZ, Hoering A, Orlowski RZ. PMID: 39321347.
      View in: PubMed   Mentions: 1     Fields:    
    4. Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel. Blood Cancer J. 2024 Aug 27; 14(1):149. Banerjee R, Biru Y, Cole CE, Faiman B, Midha S, Ailawadhi S. PMID: 39191731; PMCID: PMC11350150.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Dramatically elevated plasma vascular endothelial growth factor levels from influenza A infection in polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome: A case report. EJHaem. 2024 Aug; 5(4):842-844. Kannan A, Zhuo Y, Banerjee R. PMID: 39157604; PMCID: PMC11327705.
      View in: PubMed   Mentions:
    6. Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Impact of Intensive Chemomobilization. Transplant Cell Ther. 2024 Aug; 30(8):774.e1-774.e12. Portuguese AJ, Yeh AC, Banerjee R, Holmberg L, Wuliji N, Green DJ, Mielcarek M, Gopal AK, Gooley T, Stevenson P, Cowan AJ. PMID: 38768908; PMCID: PMC11296896.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. TACTUM: Trends in Access to Cellular Therapies in Multiple Myeloma, Perspectives of Treating Versus Referring Physicians. Transplant Cell Ther. 2024 Sep; 30(9):925.e1-925.e6. Atallah R, Ahmed N, Ayoobkhan F, Saif MSI, Logan E, Shrestha A, Anwer F, Mahmoudjafari Z, Mushtaq MU, Hashmi H, Ganguly S, McGuirk J, Shebli A, Abdallah AO, Banerjee R, Alkharabsheh O. PMID: 38763416.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Mitigating time toxicity in lymphoma and multiple myeloma. Leuk Lymphoma. 2024 Oct; 65(10):1418-1429. Di M, Su CT, Cowan AJ, Gopal AK, Banerjee R. PMID: 38749027.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma. Blood Adv. 2024 05 14; 8(9):2207-2216. Reyes KR, Liu YC, Huang CY, Banerjee R, Martin T, Wong SW, Wolf JL, Arora S, Shah N, Chari A, Chung A. PMID: 38429087; PMCID: PMC11061209.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis. Blood Cancer J. 2024 Mar 22; 14(1):52. Hoff FW, Banerjee R, Khan AM, McCaughan G, Wang B, Wang X, Roose J, Anderson LD, Cowan AJ, Rajkumar SV, Kaur G. PMID: 38519476; PMCID: PMC10959949.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinic. Blood Adv. 2024 Feb 27; 8(4):895-898. Banerjee R, Poh C, Hirayama AV, Gauthier J, Cassaday RD, Shadman M, Cowan AJ, Till BG, Green DJ, Kiem HP, Gopal AK, Maloney DG. PMID: 38197942; PMCID: PMC10875255.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    12. Financial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2024 Jul; 24(7):446-454.e3. Banerjee R, Cowan AJ, Ortega M, Missimer C, Carpenter PA, Oshima MU, Salit RB, Vo PT, Lee CJ, Mehta RS, Kuderer NM, Shankaran V, Lee SJ, Su CT. PMID: 38521640; PMCID: PMC11189752.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation. Br J Haematol. 2024 Mar; 204(3):887-891. Hammons L, Haider S, Portuguese AJ, Banerjee R, Szabo A, Pasquini M, Chhabra S, Radhakrishnan S, Mohan M, Narra R, Dong J, Janz S, Shah NN, Hamadani M, D'Souza A, Hari P, Dhakal B. PMID: 38054558.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Opportunity Strikes for Reducing Cancer Drug Waste: Bortezomib as an Example of Vial Mis-Sizing in Oncology. JCO Oncol Pract. 2024 Feb; 20(2):165-168. Abrams HR, Chen AW, Banerjee R. PMID: 37956392.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians. Blood Cancer J. 2023 11 06; 13(1):162. Banerjee R, Wang B, Anderson LD, McCaughan G, Mehra N, Cowan AJ, Rajkumar SV, Kaur G. PMID: 37926718; PMCID: PMC10625982.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Association between dexamethasone exposure and visually significant cataracts in multiple myeloma. Am J Hematol. 2024 01; 99(1):E12-E14. Banerjee R, Hurtado Martínez JA, Flores Pérez PA, Porras N, Hydren J, Ahlstrom JM, Taravati P, Cowan AJ. PMID: 37853832.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profiling. Front Oncol. 2023; 13:1240966. Banerjee R, Cicero KI, Lee SS, Cowan AJ. PMID: 37849816; PMCID: PMC10577204.
      View in: PubMed   Mentions:
    18. Randomized phase 2 study of digital life coaching during transplantation for myeloma. Bone Marrow Transplant. 2023 12; 58(12):1406-1409. Banerjee R, Huang CY, Ryan C, Lee A, Brassil KJ, Moore J, Arora S, Chung A, Wong SW, Wolf J, Martin T, Dhruva A, Shah N. PMID: 37743374.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    19. Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis. Blood Adv. 2023 06 27; 7(12):2746-2757. Ragon BK, Shah MV, D'Souza A, Estrada-Merly N, Gowda L, George G, de Lima M, Hashmi S, Kharfan-Dabaja MA, Majhail NS, Banerjee R, Saad A, Hildebrandt GC, Mian H, Abid MB, Battiwalla M, Lekakis LJ, Patel SS, Murthy HS, Nieto Y, Strouse C, Badawy SM, Al Hadidi S, Dholaria B, Aljurf M, Vesole DH, Lee CH, Pawarode A, Gergis U, Miller KC, Holmberg LA, Afrough A, Solh M, Munshi PN, Nishihori T, Anderson LD, Wirk B, Kaur G, Qazilbash MH, Shah N, Kumar SK, Usmani SZ. PMID: 36827681; PMCID: PMC10275699.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    20. Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy. Eur J Nucl Med Mol Imaging. 2023 09; 50(11):3349-3353. Banerjee R, Wang V, Huang CY, Pandita D, Leonard MK, LaRue S, Ahmadi M, Kaplan L, Ai WZ, Fakhri B, Spinner M, Seshadri MR, Pampaloni MH, Andreadis CB. PMID: 37300573; PMCID: PMC10853015.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Should I stay or should I go (to transplant)? Managing insufficient responses to induction in multiple myeloma. Blood Cancer J. 2023 05 30; 13(1):89. Banerjee R, Williams L, Mikhael JR. PMID: 37248225; PMCID: PMC10226974.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Intensity of Cyclophosphamide-Based Bridging Therapy Before Chimeric Antigen Receptor T Cell Therapy in Myeloma. Transplant Cell Ther. 2023 08; 29(8):504.e1-504.e7. Zafar A, Huang CY, Lo M, Arora S, Chung A, Wong SW, Wolf J, Martin TG, Shah N, Banerjee R. PMID: 37244643.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. Significance of the pee-value: relevance of 24-hour urine studies for patients with myeloma. Leuk Lymphoma. 2023 06; 64(6):1186-1193. Natsuhara KH, Huang CY, Knoche J, Arora S, Chung A, Martin T, Wolf J, Wong SW, Shah N, Banerjee R. PMID: 37096638.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Professional Challenges for United States Hematology/Oncology Trainees during COVID-19. Cancer Invest. 2023 Jul; 41(6):539-547. Banerjee R, Kareff SA, Leyfman Y, Dhawan N, Hammons LR, Desai A, Tsang M, Velazquez AI, Nizam A. PMID: 37017426.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    25. Demographics, Motivations, and Experiences of Participants in Transplantation or Cellular Therapy Fellowships. Transplant Cell Ther. 2023 06; 29(6):394.e1-394.e7. Banerjee R, Kelkar AH, Durani U, Anagnostou T, Nishitani M, Mallhi K, Majhail NS, Logan AC. PMID: 36934994.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma. Transplant Cell Ther. 2023 06; 29(6):350-355. Reyes KR, Huang CY, Lo M, Arora S, Chung A, Wong SW, Wolf J, Olin RL, Martin T, Shah N, Banerjee R. PMID: 36933659.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    27. Cytomegalovirus seropositivity is associated with improved responses to CD38 monoclonal antibody therapies in multiple myeloma: A single-centre retrospective study. Br J Haematol. 2023 06; 201(5):935-939. Ge AY, Huang CY, Banerjee R, Knoche J, Chung A, Arora S, Martin TG, Wolf J, Wong SW, Wiita AP, Shah N. PMID: 36846905.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    28. Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium. J Clin Oncol. 2023 05 10; 41(14):2594-2606. Wang Y, Jain P, Locke FL, Maurer MJ, Frank MJ, Munoz JL, Dahiya S, Beitinjaneh AM, Jacobs MT, Mcguirk JP, Vose JM, Goy A, Andreadis C, Hill BT, Dorritie KA, Oluwole OO, Deol A, Paludo J, Shah B, Wang T, Banerjee R, Miklos DB, Rapoport AP, Lekakis L, Ghobadi A, Neelapu SS, Lin Y, Wang ML, Jain MD. PMID: 36753699; PMCID: PMC10489553.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    29. Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma. J Oncol Pharm Pract. 2023 Oct; 29(7):1715-1724. Rath C, Yoo C, Cheplowitz H, Lo M, Young R, Guglielmo J, Saunders IM, Banerjee R, Young R, Kumar A, Chung A, Rosenberg AS, Costello C, Fine J, Wilson M, Patel N, Banez MT. PMID: 36731514.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Clinical Validation of a Continuous Monitoring Mobile Cardiac Detection Device for Atrial Fibrillation. Am J Cardiol. 2023 02 15; 189:61-63. Banerjee S, Das T, Grodin J, Minniefield N, Tsai S, Banerjee R, Persen K, Novak S. PMID: 36508764.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Innovation in BCMA CAR-T therapy: Building beyond the Model T. Front Oncol. 2022; 12:1070353. Banerjee R, Lee SS, Cowan AJ. PMID: 36505779; PMCID: PMC9729952.
      View in: PubMed   Mentions: 5  
    32. Myeloma, melphalan, and the taste of transplantation. Cancer. 2022 11 01; 128(21):3784-3786. Banerjee R. PMID: 36041229.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma. Blood Adv. 2022 07 12; 6(13):3991-3995. Kansagra A, Dispenzieri A, Fraser R, Estrada-Merly N, Sidana S, Nishihori T, Hansen DK, Anderson LD, Banerjee R, Bumma N, Dhakal B, Khouri J, Landau H, Lee C, Mian H, Nathan S, Savani B, Kumar S, Qazilbash M, Shah N, D'Souza A. PMID: 35507742; PMCID: PMC9278304.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. SNPs and PROs in myeloma: the most ambitious crossover of all time? Bone Marrow Transplant. 2022 10; 57(10):1475-1476. Banerjee R, Shah N. PMID: 35768572.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Acquired factor VII inhibitor associated with primary central nervous system Lymphoma: A case report. EJHaem. 2022 Aug; 3(3):1000-1002. Goyal V, Salmasi G, Leavitt AD, Rubenstein JL, Banerjee R. PMID: 36051043; PMCID: PMC9421997.
      View in: PubMed   Mentions: 2  
    36. Severe electrolyte derangements from lysozymuria in acute myeloid leukemia. EJHaem. 2022 Aug; 3(3):1018-1020. Pérez-Pinzón J, Olin RL, Banerjee R. PMID: 36051078; PMCID: PMC9421957.
      View in: PubMed   Mentions: 2  
    37. Financial toxicity in hematological malignancies: a systematic review. Blood Cancer J. 2022 04 22; 12(4):74. Ouchveridze E, Banerjee R, Desai A, Aziz M, Lee-Smith W, Mian H, Berger K, McClune B, Sborov D, Qazilbash M, Kumar S, Mohyuddin GR. PMID: 35459862; PMCID: PMC9033803.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    38. Digital Life Coaching During Stem Cell Transplantation: Development and Usability Study. JMIR Form Res. 2022 Mar 04; 6(3):e33701. Banerjee R, Huang CY, Dunn L, Knoche J, Ryan C, Brassil K, Jackson L, Patel D, Lo M, Arora S, Wong SW, Wolf J, Martin Iii T, Dhruva A, Shah N. PMID: 35039279; PMCID: PMC8933800.
      View in: PubMed   Mentions: 3  
    39. Complete response following treatment of plasma cell leukemia with venetoclax and dexamethasone: A case report. J Oncol Pharm Pract. 2022 Jul; 28(5):1244-1248. Vo K, Guan T, Banerjee R, Lo M, Young R, Shah N. PMID: 35084252.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Anthracyclines in a patient with acute leukemia and severe cardiomyopathy requiring mechanical support: A case report. J Oncol Pharm Pract. 2022 Apr; 28(3):729-732. Banerjee R, Lo M, Klein L, Aras M, Logan AC. PMID: 34846217.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients. Bone Marrow Transplant. 2022 02; 57(2):295-298. Tan CR, Estrada-Merly N, Landau H, Lekakis L, Banerjee R, Mian H, Usmani SZ, Hanbali A, Lazarus HM, Kyle RA, Dholaria B, Bal S, Strouse C, Murthy HS, Wirk B, Nishihori T, Kumar S, Shah N, Qazilbash M, D'Souza A. PMID: 34802047; PMCID: PMC8825695.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation. Transplant Cell Ther. 2022 02; 28(2):83.e1-83.e9. Sidana S, Kumar S, Fraser R, Estrada-Merly N, Giralt S, Agrawal V, Anderson LD, Aljurf M, Banerjee R, Bashey A, Battiwalla M, Beitinjaneh A, Chakraborty R, Chhabra S, Dhakal B, Dholaria B, Hashmi S, Janakiram M, Lee C, Lekakis L, Murthy HS, Parrondo R, Wangjam T, Usmani S, Shah N, Qazilbash M, D'Souza A. PMID: 34781066; PMCID: PMC8900987.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    43. Synthetic control arms in studies of multiple myeloma and diffuse large B-cell lymphoma. Br J Haematol. 2022 03; 196(5):1274-1277. Banerjee R, Midha S, Kelkar AH, Goodman A, Prasad V, Mohyuddin GR. PMID: 34750805.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    44. Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis. Bone Marrow Transplant. 2022 01; 57(1):31-37. Pasvolsky O, Yeshurun M, Fraser R, Estrada-Merly N, Rozovski U, Shargian-Alon L, Assal A, Banerjee R, Bumma N, Gale RP, Hagen P, Holmberg L, Hossain NM, Lazarus HM, Lee C, Mian H, Miller KC, Nathan S, Nagler A, Nishihori T, Parrondo RD, Patel S, Schroeder MA, Usmani SZ, Wang T, Wirk B, Kumar S, Shah N, Qazilbash MH, D'Souza A. PMID: 34608275; PMCID: PMC8764606.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    45. Isatuximab, carfilzomib and dexamethasone (Isa-Kd) for the management of relapsed multiple myeloma. Future Oncol. 2021 Dec; 17(35):4849-4860. Banerjee R, Lo M, Martin TG. PMID: 34553603.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    46. Lack of equipoise in the LIGHTHOUSE trial for patients with relapsed multiple myeloma: An ethical concern. Eur J Cancer. 2021 11; 157:533-535. Mohyuddin GR, Banerjee R, Goodman AM. PMID: 34544634.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Rethinking mechanisms of neurotoxicity with BCMA directed therapy. Crit Rev Oncol Hematol. 2021 Oct; 166:103453. Mohyuddin GR, Banerjee R, Alam Z, Berger KE, Chakraborty R. PMID: 34461271.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    48. Characteristics of Registered Studies of Chimeric Antigen Receptor Therapies: A Systematic Review. JAMA Netw Open. 2021 07 01; 4(7):e2115668. Banerjee R, Prasad V. PMID: 34236412; PMCID: PMC8267610.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. Toci or not toci: innovations in the diagnosis, prevention, and early management of cytokine release syndrome. Leuk Lymphoma. 2021 11; 62(11):2600-2611. Banerjee R, Fakhri B, Shah N. PMID: 34151714.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    50. Next-Generation Implementation of Chimeric Antigen Receptor T-Cell Therapy Using Digital Health. JCO Clin Cancer Inform. 2021 06; 5:668-678. Banerjee R, Shah N, Dicker AP. PMID: 34110929.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    51. The Democratization of Scientific Conferences: Twitter in the Era of COVID-19 and Beyond. Curr Hematol Malig Rep. 2021 04; 16(2):132-139. Banerjee R, Kelkar AH, Logan AC, Majhail NS, Pemmaraju N. PMID: 33788125; PMCID: PMC8011363.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma. Transplant Cell Ther. 2021 06; 27(6):477.e1-477.e7. Banerjee R, Marsal J, Huang CY, Lo M, Thiruvengadam SK, Kennedy VE, Arora S, Wolf JL, Martin TG, Wong SW, Shah N. PMID: 33831353.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    53. Maximizing Home Time for Persons With Cancer. JCO Oncol Pract. 2021 09; 17(9):513-516. Banerjee R, George M, Gupta A. PMID: 33661703.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    54. Driving distances and loss to follow-up after hematopoietic cell transplantation. EJHaem. 2021 May; 2(2):272-275. Banerjee R, Loren AW. PMID: 35845266; PMCID: PMC9175729.
      View in: PubMed   Mentions: 2  
    55. When and How to Treat Relapsed Multiple Myeloma. Am Soc Clin Oncol Educ Book. 2021 Mar; 41:358-375. Nathwani N, Bertamini L, Banerjee R, Gay F, Shah N, Krishnan A. PMID: 34010043.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    56. 'Stat' workflow modifications to expedite care after needlestick injuries. Occup Med (Lond). 2021 02 06; 71(1):20-24. Smith JL, Banerjee R, Linkin DR, Schwab EP, Saberi P, Lanzi M. PMID: 33399827.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    57. Benzodiazepine and zolpidem prescriptions during autologous stem cell transplantation. EJHaem. 2021 May; 2(2):276-279. Banerjee R, Lazar AA, Dunn L, Knoche J, Lo M, Arora S, Wong SW, Wolf JL, Martin TG, Dhruva A, Shah N. PMID: 35845271; PMCID: PMC9175938.
      View in: PubMed   Mentions: 3  
    58. Pragmatic trials with prespecified subgroups: what oncologists can learn from COVID-19. Nat Rev Clin Oncol. 2021 01; 18(1):7-8. Banerjee R, Prasad V. PMID: 33139895; PMCID: PMC7604917.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    59. Virtual Conferences: Optimizing Oncology Nurses' Experience. Clin J Oncol Nurs. 2020 12 01; 24(6):699-702. Brassil KJ, Banerjee R. PMID: 33216062.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    60. Driving Distance and Patient-Reported Outcomes in Hematopoietic Cell Transplantation Survivors. Biol Blood Marrow Transplant. 2020 11; 26(11):2132-2138. Banerjee R, Yi JC, Majhail NS, Jim HSL, Uberti J, Whalen V, Loren AW, Syrjala KL. PMID: 32781287; PMCID: PMC7414780.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    61. Are Observational, Real-World Studies Suitable to Make Cancer Treatment Recommendations? JAMA Netw Open. 2020 07 01; 3(7):e2012119. Banerjee R, Prasad V. PMID: 32729916.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    62. Profanities, Promises, and Hospices. J Clin Oncol. 2019 07 01; 37(19):1677-1678. Banerjee R. PMID: 31026213.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    63. Postdischarge Emergency Department Visits: Good, Bad, or Ugly? J Hosp Med. 2018 Sep; 13(9):646-647. Banerjee R, Greysen SR. PMID: 29538470.
      View in: PubMed   Mentions: 1     Fields:    
    64. Late effects of blood and marrow transplantation. Haematologica. 2017 11; 102(11):e465. Banerjee R, Luskin MR, Loren AW. PMID: 29079647; PMCID: PMC5664410.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    65. If You Book It, Will They Come? Attendance at Postdischarge Follow-Up Visits Scheduled by Inpatient Providers. J Hosp Med. 2017 08; 12(8):618-625. Banerjee R, Suarez A, Kier M, Honeywell S, Feng W, Mitra N, Grande D, Myers J. PMID: 28786427.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    66. Resilience Through Grieving Rounds. Acad Med. 2017 Jul; 92(7):900. Banerjee R. PMID: 28654521.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    67. Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced-dose ibrutinib: results from a multi-centre study. Br J Haematol. 2018 04; 181(2):259-261. Mato AR, Timlin C, Ujjani C, Skarbnik A, Howlett C, Banerjee R, Nabhan C, Schuster SJ. PMID: 28220935.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    68. Illiteracy. The Pharos of Alpha Omega Alpha Honor Medical Society. 2017; 80(1):65. Banerjee R.
    69. Coloring the Silence. Acad Med. 2016 08; 91(8):1088. Banerjee R. PMID: 27465091.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    70. A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies. Curr Hematol Malig Rep. 2015 Sep; 10(3):225-36. Luskin MR, Banerjee R, Del Percio S, Loren AW. PMID: 26162948.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. Occurrence and recall rates of fertility discussions with young breast cancer patients. Support Care Cancer. 2016 Jan; 24(1):163-171. Banerjee R, Tsiapali E. PMID: 25967235.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    72. Medical student awareness of and interest in clinical informatics. J Am Med Inform Assoc. 2015 Apr; 22(e1):e42-7. Banerjee R, George P, Priebe C, Alper E. PMID: 25726567; PMCID: PMC7659213.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    73. To comfort, always. J Palliat Med. 2014 Mar; 17(3):365-6. Banerjee R. PMID: 24548284.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. The human alpha defensin HD5 neutralizes JC polyomavirus infection by reducing endoplasmic reticulum traffic and stabilizing the viral capsid. J Virol. 2014 Jan; 88(2):948-60. Zins SR, Nelson CD, Maginnis MS, Banerjee R, O'Hara BA, Atwood WJ. PMID: 24198413; PMCID: PMC3911681.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    75. Lyme neuroborreliosis presenting with alexithymia and suicide attempts. J Clin Psychiatry. 2013 Oct; 74(10):981. Banerjee R, Liu JJ, Minhas HM. PMID: 24229748.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    76. Unique susceptibility of a human lung carcinoid tumor cell line to infection with BK virus. Virus Res. 2010 Apr; 149(1):128-32. Haley SA, O'Hara BA, Banerjee R, Atwood WJ. PMID: 20122973.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    Rahul's Networks
    Concepts (236)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (25)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.